| Date | Time | Source | Headline | Symbol | Company |
| 04/12/2021 | 4:05PM | Business Wire | Interparfums SA Completes the Acquisition of Its Future Headquarters in Paris | NASDAQ:IPAR | Inter Parfums Inc |
| 04/09/2021 | 1:43PM | Business Wire | ImmunoPrecise lance le programme d'anticorps candidat TATX-112 pour le traitement du cancer et de la maladie d'Alzheimer | NASDAQ:IPAR | Inter Parfums Inc |
| 04/08/2021 | 8:02AM | Business Wire | ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease | NASDAQ:IPAR | Inter Parfums Inc |
| 03/25/2021 | 5:02PM | Business Wire | ImmunoPrecise identifie un anticorps unique, le 23-H7, qui démontre une efficacité in vivo, un mécanisme d'action alternat... | NASDAQ:IPAR | Inter Parfums Inc |
| 03/25/2021 | 9:03AM | Business Wire | ImmunoPrecise Identifies a Unique Antibody, 23-H7, That Demonstrates In Vivo Efficacy, an Alternative Mechanism of Action & B... | NASDAQ:IPAR | Inter Parfums Inc |
| 03/18/2021 | 2:56PM | Business Wire | ImmunoPrecise publie ses résultats financiers et les principaux éléments de son activité récente pour le troisième trim... | NASDAQ:IPAR | Inter Parfums Inc |
| 03/17/2021 | 6:48PM | Business Wire | ImmunoPrecise Reports Financial Results and Recent Business Highlights for Third Quarter of 2021 Fiscal Year | NASDAQ:IPAR | Inter Parfums Inc |
| 03/16/2021 | 5:51PM | Business Wire | ImmunoPrecise Antibodies annonce les résultats d'un criblage complet de 27 anticorps thérapeutiques propriétaires anti-SAR... | NASDAQ:IPAR | Inter Parfums Inc |
| 03/16/2021 | 7:29AM | Business Wire | ImmunoPrecise Antibodies Announces Results from a Comprehensive Screening of 27 Proprietary Anti-SARS-CoV-2 Therapeutic Antib... | NASDAQ:IPAR | Inter Parfums Inc |
| 03/12/2021 | 4:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPAR | Inter Parfums Inc |
| 03/11/2021 | 4:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPAR | Inter Parfums Inc |
| 03/04/2021 | 3:26PM | Business Wire | ImmunoPrecise annonce sa participation à la Conférence mondiale des sciences de la vie organisée par H.C. Wainwright les 9... | NASDAQ:IPAR | Inter Parfums Inc |
| 03/04/2021 | 7:28AM | Business Wire | ImmunoPrecise Announces Participation at the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021 (Virtual Con... | NASDAQ:IPAR | Inter Parfums Inc |
| 03/02/2021 | 9:32AM | TipRanks | Inter Parfums Lifts 2021 Outlook After 4Q Beat; Street Sees 12% Downside | NASDAQ:IPAR | Inter Parfums Inc |
| 03/01/2021 | 4:54PM | Business Wire | Inter Parfums, Inc. Reports 2020 Fourth Quarter and Year End Results | NASDAQ:IPAR | Inter Parfums Inc |
| 03/01/2021 | 4:13PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IPAR | Inter Parfums Inc |
| 03/01/2021 | 4:05PM | Business Wire | Inter Parfums, Inc. Reports 2020 Fourth Quarter & Year End Results Increases 2021 Guidance & Reinstates Quarterly Cash Dividend | NASDAQ:IPAR | Inter Parfums Inc |
| 03/01/2021 | 3:56PM | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:IPAR | Inter Parfums Inc |
| 02/20/2021 | 6:40PM | Business Wire | ImmunoPrecise présente les données de l'étude préclinique du cocktail d'anticorps monoclonaux TATX-03 PolyTope™ pour lu... | NASDAQ:IPAR | Inter Parfums Inc |
| 02/19/2021 | 7:28AM | Business Wire | ImmunoPrecise Announces Data from Preclinical Study of TATX-03 PolyTope™ Monoclonal Antibody Cocktail Candidate Against COV... | NASDAQ:IPAR | Inter Parfums Inc |
| 02/18/2021 | 9:00AM | Business Wire | Inter Parfums, Inc. Schedules Release of Its 2020 Fourth Quarter & Full Year Results on Monday, March 1st & Conference Call o... | NASDAQ:IPAR | Inter Parfums Inc |
| 02/12/2021 | 10:03AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:IPAR | Inter Parfums Inc |
| 02/11/2021 | 4:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPAR | Inter Parfums Inc |
| 02/11/2021 | 1:54AM | Business Wire | IPA annonce la clôture de l'option d'attribution excédentaire associée au récent placement d’actions ordinaires par voi... | NASDAQ:IPAR | Inter Parfums Inc |
| 02/10/2021 | 6:54PM | Business Wire | IPA Announces Closing of Over-Allotment Option Associated with the Recently Completed Bought Deal Offering of Common Shares | NASDAQ:IPAR | Inter Parfums Inc |
| 02/10/2021 | 11:17AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IPAR | Inter Parfums Inc |
| 02/09/2021 | 3:09AM | Business Wire | IPA annonce la clôture d’un placement d’actions ordinaires par voie de prise ferme de 21,7 millions de dollars | NASDAQ:IPAR | Inter Parfums Inc |
| 02/08/2021 | 5:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPAR | Inter Parfums Inc |
| 02/08/2021 | 4:01PM | Business Wire | IPA Announces Closing of $21.7 Million Bought Deal Offering of Common Shares | NASDAQ:IPAR | Inter Parfums Inc |
| 02/05/2021 | 5:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPAR | Inter Parfums Inc |